Sodium Oxybate in the Management of Narcolepsy: One Molecule, Three Formulations – and the Critical Role of Shared Decision-Making in Its Use




CME show

Summary: Host: Clete A. Kushida, MD, PhD <br> Guest: Michael J. Thorpy, MD <br> <p><span xml:lang="EN-US" data-contrast="auto">Three different sodium oxybate formulations are available for the management of narcolepsy with/without cataplexy. While they are equally efficacious, there are differences such as dosing that require shared decision</span><span xml:lang="EN-US" data-contrast="auto">-</span> <span xml:lang="EN-US" data-contrast="auto">making between patient and clinician to select the right formulation for each patient. Join Drs. Kushida and Thorpy as they </span><span xml:lang="EN-US" data-contrast="auto">share their approach </span><span xml:lang="EN-US" data-contrast="auto">to </span><span xml:lang="EN-US" data-contrast="auto">ma</span><span xml:lang="EN-US" data-contrast="auto">king the right treatment decision for each patient, one that includes ensuring patient preferences are considered.</span></p>